Brand name authorized in: Austria
The drug AGLANDIN RETARD contains one active pharmaceutical ingredient (API):
Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: